Market Research Reports, Inc.

MarketResearchReports.Com: Cancer Diagnostics Partnering Terms and Agreements, New Report Launched

 

Lewes, DE -- (ReleaseWire) -- 06/10/2014 -- The Cancer Diagnostics Partnering Agreements report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.

- Trends in cancer diagnostics partnering deals
- Disclosed headlines, upfronts, milestones and royalties by stage of development
- Cancer diagnostics partnering contract documents
- Top cancer diagnostics deals by value

The Cancer Diagnostics Partnering Agreements report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides an understanding and analysis of how and why companies enter cancer diagnostics partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors diagnostics technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. The report also includes companion, imaging, CT, MRI, ultrasound, in vitro, molecular, prognostics and theranostics diagnostics deals and alliances.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.

This report contains over 900 links to online copies of actual cancer diagnostics deals and where available, contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

For more information see - http://www.marketresearchreports.com/current-partnering/cancer-diagnostics-partnering-terms-and-agreements

Report scope -
Cancer Diagnostics Partnering Agreements is intended to provide the reader with an in-depth understanding and access to cancer monoclonal antibody trends and structure of deals entered into by leading companies worldwide.

Cancer Diagnostics Partnering Agreements includes:
- Trends in cancer diagnostics dealmaking in the biopharma industry since 2009
- Analysis of cancer diagnostics deal structure
- Access to headline, upfront, milestone and royalty data
- Access to over 900 cancer diagnostics deal records
- The leading cancer diagnostics deals by value since 2009
- Includes companion, imaging, CT, MRI, ultrasound, in vitro, molecular, prognostics and theranostics diagnostics deals and alliances since 2007

In Cancer Diagnostics Partnering Agreements, the available deals are listed by:
- Company A-Z
- Headline value
- Stage of development at signing
- Deal component type
- Specific oncology therapy target
- DIagnostics type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Benefits
Cancer Diagnostics Partnering Agreements provides the reader with the following key benefits:
- In-depth understanding of cancer diagnostics deal trends since 2009
- Access to headline, upfront, milestone and royalty data
- Acces to the structure of cancer diagnostics agreements with numerous real life case studies
- Comprehensive access to over 900 actual cancer diagnostics deals entered into by the world’s biopharma companies
- Insight into the terms included in a cancer diagnostics agreement, together with real world clause examples
- Understand the key deal terms companies have agreed in previous deals
- Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Spanning over 1080 pages, “Cancer Diagnostics Partnering Terms and Agreements” report covering the Trends in cancer diagnostics dealmaking, Leading cancer diagnostics deals, Big pharma cancer diagnostics deals, Cancer diagnostics dealmaking contracts directory, Cancer diagnostics dealmaking by specific therapy type, Cancer diagnostics dealmaking by specific technology type, Partnering resource center, Appendix.

Find all Deals and Alliances (Pharma & Healthcare) Reports at: http://www.marketresearchreports.com/deals-alliances-pharma-healthcare

About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

For latest market research presentations visit: http://www.marketresearchdocs.com